middle.news
Argent BioPharma Advances Cannabinoid Epilepsy Treatment at Slovenia’s Top Hospital
9:35am on Tuesday 8th of July, 2025 AEST
•
Healthcare
Read Story
Argent BioPharma Advances Cannabinoid Epilepsy Treatment at Slovenia’s Top Hospital
9:35am on Tuesday 8th of July, 2025 AEST
Key Points
EU-GMP cannabinoid API now routinely supplied to Slovenia’s largest hospital
Supply follows successful pilot program and regulatory collaboration
Builds on CannEpil®’s established European market presence
Supports neurologist-led protocols for refractory epilepsy treatment
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Argent Biopharma (ASX:RGT)
OPEN ARTICLE